| Product NDC: | 0065-0246 |
| Proprietary Name: | Betoptic S |
| Non Proprietary Name: | betaxolol hydrochloride |
| Active Ingredient(s): | 2.8 mg/mL & nbsp; betaxolol hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0065-0246 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019845 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960115 |
| Package NDC: | 0065-0246-15 |
| Package Description: | 15 mL in 1 BOTTLE, PLASTIC (0065-0246-15) |
| NDC Code | 0065-0246-15 |
| Proprietary Name | Betoptic S |
| Package Description | 15 mL in 1 BOTTLE, PLASTIC (0065-0246-15) |
| Product NDC | 0065-0246 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | betaxolol hydrochloride |
| Dosage Form Name | SUSPENSION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19960115 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | BETAXOLOL HYDROCHLORIDE |
| Strength Number | 2.8 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |